This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As cardiothoracic surgery continues to evolve, STS has responded by adding new risk models to guide treatment decisions and benchmark performance,” said STS President Jennifer C. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5% Romano , MD, MS. and 4.1%, respectively.
The conference, healthcare’s leading scientific and educational convening specializing in cardiothoracic surgery, has a rich history of showcasing clinical trials with a strong foundation of detailed methodology and trusted data collection governed by ethical clinical principles.
Myocardial fibrosis is a critical link in preventing the progression of heartdisease. This study conducted a bibliometric analysis of its mechanism to identify trends and hotspots, aiming to provide valuable.
The Health Resources and Services Administration administering the PSLRP is accepting applications through July 20, 2023. Eligibility To qualify for the program, applicants must be a U.S. Find out if you’re eligible and apply here by July 20, 2023, 7:30 p.m. Congenital heartdisease (CHD) is the number one birth defect in the U.S.,
Kitsis’ pioneering research on the basic mechanisms of cardiovascular disease has opened up new therapeutic avenues for patients following a heart attack or stroke,” said Ernest Mazzaferri, MD , co-interim director of Ohio State’s Heart and Vascular Center and an interventional cardiologist.A
narrates and is a co-producer of a documentary focused on radiation and orthopedic injuries suffered by doctors and nurses who work in cardiac catheterization laboratories where they apply the very latest non-surgical technologies to treat the world’s leading cause of death, heartdisease. Rizik , M.D., Diethrich , M.D.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content